Results 141 to 150 of about 5,794,212 (304)

Role of clinical pharmacist in community pharmacy

, 2020
Klīniskā farmaceita uzdevums ir panākt optimālu zāļu lietošanu. Darba mērķis ir apkopot informāciju par klīniskā farmaceita veiktajām konsultācijām aptiekā un veikt farmaceitiskās aprūpes speciālistu un ārstniecības personu anketēšanu par klīniskā ...
Katkeviča, Linda
core  

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Antimicrobial Resistance: Research and Action Towards the One Health Approach

Journal of Infection and Public Health, 2023
Nour Shamas, Henry Baffoe-Bonnie
doaj   +1 more source

The Patient Perspectives of Clinical Pharmacist Services in Hospitals and Clinics: A Focused Narrative Review of Qualitative Studies. [PDF]

Basic Clin Pharmacol Toxicol
Henriksen BT, Gillespie U, Mathiesen L, Andersson Y.   +3 more
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Geriatric patients' views on a pharmacist-led follow-up programme after discharge from hospital

Background: Medication-related problems (MRPs) are common during transitions of care and can lead to hospital readmissions. This patient safety issue is especially pronounced among geriatric patients. In a randomised controlled trial (RCT), the effect of
Gallego, Gisselle, Svahn, Sofia, Gustafsson, Maria,, Håkansson Lindqvist, Marcia,, Gallego, Gisselle,, Marcia Håkansson Lindqvist, Gustafsson, Maria, Sofia Svahn, Håkansson Lindqvist, Marcia, Gisselle Gallego, Svahn, Sofia,, Maria Gustafsson   +11 more
core   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Pharmacist-led lipid clinic for surgical patients with peripheral vascular disease

, 2012
Pharmacist-led lipid clinic for surgical patients with peripheral vascular ...
R Fyfe (13415811), GR Weeks (15875087), J Amerena (13358346), J George (7791293)   +3 more
core  

Clinical pharmacists in general practice [PDF]

British Journal of General Practice, 2018
Louise S, Deeks, Sam, Kosari, Mark, Naunton   +2 more
openaire   +2 more sources